The specialty enzymes market is expected to grow from $6.1 billion in 2024 to $9.2 billion by 2029. This growth represents a compound annual growth
Category: News
Why Investors Are Watching Sana Biotechnology’s Rollercoaster Ride
Sana Biotechnology’s shares fell 6.2%, highlighting recent market volatility. Trading volume drastically decreased to 2.4 million shares, significantly below the average of 16.5 million. Analysts
Breaking Frontiers in Cancer Treatment: Tango Therapeutics’ Vision Revealed at Upcoming Conference
Tango Therapeutics is presenting innovative approaches to cancer treatment at the Guggenheim SMID Cap Biotechnology Conference on February 5, 2025. Dr. Barbara Weber, President and
Biotech Boom: How AI is Driving a $805 Billion Revolution
The global biotech market is expected to grow by $805.6 billion from 2025 to 2029. Anticipated compound annual growth rate (CAGR) is 12.4% during this
Revolutionizing Biotech: Dipal Doshi Joins Azenta’s Board of Directors
Dipal Doshi has been appointed to the Board of Directors at Azenta, Inc., marking a significant change in the company’s governance. His extensive experience in
Breakthrough Partnership: Disperazol Pharma Takes Bold Steps Against Global Antibiotic Resistance
Disperazol Pharma partners with AMR Industry Alliance to combat antimicrobial resistance (AMR). Over 1.27 million deaths occur yearly due to AMR-related infections, highlighting the urgent
Genetically Modified Pigs for Human Transplants: Controversy Brews in East Houston
United Therapeutics plans to build a 22-acre facility in East Houston for breeding genetically modified pigs. The pigs are engineered to grow kidneys for human
Revolutionary Cancer Treatment: This Startup’s Game-Changing Approach Could Save Lives
In a bold move to transform cancer treatment, Commit Biologics A/S is securing funding to propel its innovative Bispecific Complement Engaging (BiCE™) platform. This groundbreaking
Missing Elephant Returns to the Jungle! New Merchandise Unveiled
Exciting updates are sweeping through the world’s favorite theme parks! After an unexpected absence, the beloved elephant has made its triumphant return to the Jungle
Stock Surge: Sana Biotechnology’s Dramatic Leap
Recent Movements in Sana Biotechnology’s Stock On Wednesday, Sana Biotechnology, Inc. saw its stock price soar by a remarkable 13.9%. The share value reached a